The Role of Speckle Tracking for Differentiating Patients with Hypertensive Cardiac Hypertrophy from Athlete’s with Moderate Left Ventricular Hypertrophy
Al-Rabat, K., Fouad, B., Ebaid, H., ALAzab, D. (2022). The Role of Speckle Tracking for Differentiating Patients with Hypertensive Cardiac Hypertrophy from Athlete’s with Moderate Left Ventricular Hypertrophy. EKB Journal Management System, 7(10), 55-59. doi: 10.21608/bjas.2022.288239
K.E. Al-Rabat; B.E. Fouad; H.H. Ebaid; D.A. ALAzab. "The Role of Speckle Tracking for Differentiating Patients with Hypertensive Cardiac Hypertrophy from Athlete’s with Moderate Left Ventricular Hypertrophy". EKB Journal Management System, 7, 10, 2022, 55-59. doi: 10.21608/bjas.2022.288239
Al-Rabat, K., Fouad, B., Ebaid, H., ALAzab, D. (2022). 'The Role of Speckle Tracking for Differentiating Patients with Hypertensive Cardiac Hypertrophy from Athlete’s with Moderate Left Ventricular Hypertrophy', EKB Journal Management System, 7(10), pp. 55-59. doi: 10.21608/bjas.2022.288239
Al-Rabat, K., Fouad, B., Ebaid, H., ALAzab, D. The Role of Speckle Tracking for Differentiating Patients with Hypertensive Cardiac Hypertrophy from Athlete’s with Moderate Left Ventricular Hypertrophy. EKB Journal Management System, 2022; 7(10): 55-59. doi: 10.21608/bjas.2022.288239

The Role of Speckle Tracking for Differentiating Patients with Hypertensive Cardiac Hypertrophy from Athlete’s with Moderate Left Ventricular Hypertrophy

Benha Journal of Applied Sciences
Article 8, Volume 7, Issue 10, October 2022, Page 55-59  XML PDF (492.03 K)
Document Type: Original Research Papers
DOI: 10.21608/bjas.2022.288239
View on SCiNiTO View on SCiNiTO
Authors
K.E. Al-Rabat; B.E. Fouad; H.H. Ebaid; D.A. ALAzab
Cardiology, Faculty of Medicine, Benha University
Abstract
Hypertensive cardiac hypertrophy is a leading cause of morbidity and death, which motivates our study's focus on these issues. Conditions include heart attacks, irregular heartbeats, diastolic dysfunction, heart failure, and sudden cardiac death fall under this category. A concentric cardiac hypertrophy pattern, like that seen in hypertensive hypertrophy, is also seen in athletes who participate in intense strength training. On the other hand, unlike hypertension hypertrophy, which may have dire consequences, athletic hypertrophy is generally seen as a harmless physiologic response. The research aimed to use speckle tracking echocardiography to identify mild LVH in athletes and distinguish it from hypertensive LVH in patients. A total of 105 participants were included in this prospective case control study and were randomly assigned to one of three groups: 45 healthy, inactive people served as the "healthy group." Patients with hypertension-related LVH numbered 30, whereas athletes with concentric LVH numbered 30 in the athletes group. The results showed that there were no statistically significant differences (p>0.05) in age, height, or body mass index between the groups that were analysed. The mean body mass index was significantly different between the three groups (p= 0.005). Heart rate, systolic blood pressure, and diastolic blood pressure all differed significantly (p0.001) across the three groups. The heart rates of the healthy and athletic groups were found to be significantly lower than those of the hypertension group.
Keywords
Cardiac; Hypertrophy; Athlete’s; HTN
Statistics
Article View: 87
PDF Download: 159